Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions with antibacterial agents

J R Horn1, P D Hansten

  • 1Department of Pharmacy, School of Pharmacy, University of Washington, Seattle 98195, USA.

The Journal of Family Practice
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An evaluation of the potential drug interaction between warfarin and levothyroxine.

Journal of thrombosis and haemostasis : JTH·2014
Same author

Review article: similarities and differences among delayed-release proton-pump inhibitor formulations.

Alimentary pharmacology & therapeutics·2005
Same author

Comparative pharmacology of proton pump inhibitors.

Managed care (Langhorne, Pa.)·2001
Same author

Van't Hoff and calorimetric enthalpies from isothermal titration calorimetry: are there significant discrepancies?

Biochemistry·2001
Same author

ORCA: OpeRational ClassificAtion of drug interactions.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Same author

Performance of community pharmacy drug interaction software.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023
Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023
Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023
Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023
Same journal

Renewing the dream.

The Journal of family practice·2023
Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023
See all related articles

Antibacterial drugs can interact with other medications, affecting how they work or how the body processes them. Understanding these drug interactions helps physicians avoid adverse reactions by selecting appropriate antibacterial agents.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Antibacterial drugs are frequently co-administered with other medications.
  • Drug interactions involving antibacterials can alter pharmacokinetics or pharmacodynamics.
  • Interactions may involve changes in absorption, hepatic metabolism, or renal elimination.

Purpose of the Study:

  • To review clinically significant drug interactions involving antibacterial agents.
  • To highlight the importance of understanding drug interactions for safe prescribing.
  • To inform clinicians on appropriate drug selection to minimize adverse events.

Main Methods:

  • Literature review of drug interactions involving common antibacterial classes.
  • Analysis of mechanisms of interaction (pharmacokinetic and pharmacodynamic).

Related Experiment Videos

  • Discussion of clinical significance and implications for drug selection.

    • Main Results:

    • Various antibacterial classes (quinolones, macrolides, etc.) exhibit significant drug interactions.
    • Interaction potential varies among different antibacterial agents within a class.
    • Mechanisms include altered drug absorption, metabolism, and elimination.

    Conclusions:

    • Clinicians must be aware of potential drug interactions with antibacterial agents.
    • Appropriate drug selection based on interaction profiles is crucial.
    • Understanding these interactions can prevent adverse drug reactions and improve patient outcomes.